NovoCure stockNVCR
NovoCure trades at $13.55, 36.8% below its 52-week high (Jul 24, 2026). The price is below its 50- and 200-day averages, a downtrend. +4.8% year to date, +16.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.
Ratings, candles, signals and the screener for NVCR — after you log in
Open the terminalFrequently asked questions about NovoCure
What is the NovoCure stock price?
At the close on Nov 5, 2026: $13.55 (−7.26% on the day). 52-week high: $21.45 on Jul 24, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does NovoCure report earnings?
The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed +73% year over year, revenue +16%.
Does NovoCure pay dividends?
No, NovoCure does not pay dividends.
Where does NovoCure trade and how to buy it?
Ticker NVCR, exchange Nasdaq, listed since 2015. You can buy it through a broker with access to US exchanges.
Should I buy NovoCure now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for NVCR are in the terminal after you log in.